Mulmit

TENAX THERAPEUTICS, INC.TENAX THERAPEUTICS, INC.

TENX Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-310-56,385,000-52,600,000-1.34
2024-12-310-19,494,000-17,600,000-1.15

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-09-16Doogan Declan53,000
2026-09-15Giordano Christopher ThomasCEO4,850
2026-09-11Giordano Christopher ThomasCEO6,000
2026-09-11STAAB THOMAS R IIChief Financial Officer5,675
2026-09-03ADAR1 Capital Management, LLC900,000
2026-09-02ADAR1 Capital Management, LLC187,704
2026-09-01ADAR1 Capital Management, LLC179,058
2026-08-31ADAR1 Capital Management, LLC403,571
2026-08-24ADAR1 Capital Management, LLC107,374
2026-08-21ADAR1 Capital Management, LLC716,369
2026-08-20ADAR1 Capital Management, LLC202,124
2026-07-13Giordano Christopher ThomasCEO219

8-K events

FiledItems
2026-09-09Regulation FD disclosure · Financial statements and exhibits
2026-08-10Other events · Financial statements and exhibits
2026-07-31Results of operations · Financial statements and exhibits
2026-07-02Other events · Financial statements and exhibits
2026-06-30Entry into a material agreement · Financial statements and exhibits
2026-06-29Officer or director change · Other events · Financial statements and exhibits
2026-06-04Submission of matters to a vote
2026-05-12Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…